Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2059-0105
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies ; volume:3 ; number:1 ; day:27 ; month:2 ; year:2018 ; pages:1-9 ; date:12.2018
npj vaccines ; 3, Heft 1 (27.2.2018), 1-9, 12.2018
- Creator
-
Bittar, Alice
- Contributor
-
Sengupta, Urmi
Kayed, Rakez
SpringerLink (Online service)
- DOI
-
10.1038/s41541-018-0046-8
- URN
-
urn:nbn:de:1111-2018041612049
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bittar, Alice
- Sengupta, Urmi
- Kayed, Rakez
- SpringerLink (Online service)
Other Objects (12)
Alzheimer’s disease and immunotherapy
Active immunotherapy options for Alzheimer’s disease
Immunotherapy for Alzheimer’s disease: hoops and hurdles
Passive immunotherapy for Alzheimer’s disease: challenges & future directions
Strain-specific profiling of Amyloid-β in Alzheimer´s disease: functional and clinical signature
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer’s disease
Sex-specific associations of matrix metalloproteinases in Alzheimer’s disease
Sex-specific DNA methylation differences in Alzheimer’s disease pathology
Distinct sex-specific DNA methylation differences in Alzheimer’s disease
Cell-type-specific Alzheimer’s disease polygenic risk scores are associated with distinct disease processes in Alzheimer’s disease
Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
Alzheimer’s disease and immunotherapy
Active immunotherapy options for Alzheimer’s disease
Immunotherapy for Alzheimer’s disease: hoops and hurdles
Passive immunotherapy for Alzheimer’s disease: challenges & future directions
Strain-specific profiling of Amyloid-β in Alzheimer´s disease: functional and clinical signature
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer’s disease
Sex-specific associations of matrix metalloproteinases in Alzheimer’s disease
Sex-specific DNA methylation differences in Alzheimer’s disease pathology
Distinct sex-specific DNA methylation differences in Alzheimer’s disease
Cell-type-specific Alzheimer’s disease polygenic risk scores are associated with distinct disease processes in Alzheimer’s disease
Should development of Alzheimer’s disease-specific intravenous immunoglobulin be considered?
Alzheimer’s disease and immunotherapy
Active immunotherapy options for Alzheimer’s disease
Immunotherapy for Alzheimer’s disease: hoops and hurdles
Passive immunotherapy for Alzheimer’s disease: challenges & future directions
Strain-specific profiling of Amyloid-β in Alzheimer´s disease: functional and clinical signature
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
Prospects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer’s disease
Sex-specific associations of matrix metalloproteinases in Alzheimer’s disease
Sex-specific DNA methylation differences in Alzheimer’s disease pathology
Distinct sex-specific DNA methylation differences in Alzheimer’s disease
Cell-type-specific Alzheimer’s disease polygenic risk scores are associated with distinct disease processes in Alzheimer’s disease